The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | C | Cardiovascular system | |
| 2 | C05 | Vasoprotectives | |
| 3 | C05B | Antivaricose therapy | |
| 4 | C05BA | Heparins or heparinoids for topical use |
| Code | Title | |
|---|---|---|
| C05BA01 | Organo-heparinoid | |
| C05BA02 | Sodium apolate | |
| C05BA03 | Heparin | |
| C05BA04 | Pentosan polysulfate sodium | |
| C05BA51 | Heparinoid, combinations | |
| C05BA53 | Heparin, combinations |
| Active Ingredient | Description | |
|---|---|---|
| Heparin |
Heparin is an anticoagulant and acts by inhibiting thrombin and by potentiating the naturally occurring inhibitors of activated Factor X (Xa). |
|
| Pentosan polysulfate |
The hypothetic mechanism of action of pentosan polysulfate includes a local effect in the bladder after systemic administration and excretion into the urine by binding of glycosaminoglycans to the deficient mucous of the bladder. It is hypothesized, that a potential barrier function of pentosan polysulfate instead of the damaged urothelial mucus might play a role as well the antiinflammatory activity of pentosan polysulfate sodium. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| HIRUDOID Cream | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| LIOTON Gel | Υπουργείο Υγείας (CY) | MPI, EU: SmPC |
